Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2017-05-17

Clinical Trial Update: Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997

View source ↗

Summary

A biomarker analysis update using samples from patients with chronic lymphocytic leukemia treated on the ECOG-2997 clinical trial.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: ECOG-ACRIN Cancer Research Group | Conditions: Leukemia | Status: COMPLETED